| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a25bde6b67cfcdf74fbf2690e487848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fc8616af1393b5e5fd80d4452bf99fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ced449f34d9f7f588b79d0c555fa097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd5d56962fccd895608d0b0164073c81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f7d626efbee948731a485ff8677c253
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_085579f474648dfd36df93273585f670 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01 |
| filingDate |
2010-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb019580504a956cab33b0929a4c2a93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93f30aca8c5e2d14b0af516e654dec21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17932ccfc5438b360290b1006c2efd32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d22aba6211ed2733e8d1cbebf47bf128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59ceb48cb0e488e5d5f2c4460ffdef77 |
| publicationDate |
2011-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011066659-A1 |
| titleOfInvention |
Method of regulating ppar, obesity related pathways and their associated metabolic impact |
| abstract |
It is disclosed a method of modulating a peroxisome proliferator activated receptor (PPAR) activity in a patient comprising administering to said subject an effective amount of a malleable protein matrix (MPM), uses thereof and pharmaceutical compositions comprising MPM for treating obesity related disorders and their associated metabolic impact by modulating PPAR activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10245291-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808493-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101809695-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015329923-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014046722-A1 |
| priorityDate |
2009-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |